Aimed Alliance
Navigate
  • Home
  • About
    • Mission, Vision, Beliefs
    • Staff
    • Board of Directors
    • Aimed Alliance Supporters
    • Annual Reports
    • Privacy Policy
  • Policy Priorities
  • Initiatives
    • Alternative Funding Programs
    • Copay Accumulator 101
    • Judicial Advocacy
    • Know Your Rights
    • New York Step Therapy Reform
    • Prescription Drug Affordability Boards
  • Resources
    • All
    • Stakeholders
    • Aimed in the News
    • Health News & Lawsuits
    • Newsletters & Media
  • Maps
    • Bad Drug Ads
      • Active Legislation
      • Enacted Laws
    • Copay Accumulators
      • Active Legislation
      • Enacted Laws
    • Nonmedical Switching
      • Active Legislation
      • Enacted Laws
    • Prior Authorization
      • Active Legislation
      • Enacted Laws
    • Step Therapy
      • Active Legislation
      • Enacted Laws
    • Biomarker Testing
      • Active Legislation
      • Enacted Laws
    • Oral Parity
      • Enacted Laws
  • Events
  • Contact

Aimed Alliance Releases Its Position Statement on Biosimilars

0
By Aimed Alliance on July 27, 2018 Aimed Activity, Policymakers, Reports & Papers, Resources

Aimed Alliance Releases Its Position Statement on Biosimilars. Read here.

Last Updated on May 13, 2020 by Aimed Alliance

Education FDA Federal Nonmedical Switching
Share. Twitter Facebook Pinterest LinkedIn Tumblr Email

Related Posts

  • June 5, 2025

    Judicial Advocacy 101: Tactics, Trends, and Tools

  • June 3, 2025

    Aimed Alliance Opposes Nevada’s MFP Bill

  • June 2, 2025

    Aimed Alliance Urges for Clarity in Summary of Benefits

Comments are closed.

  • Aimed Alliance

  • Aimed Alliance is a 501 (c)(3) not-for-profit health policy organization that protects and enhances the rights of health care consumers and professionals.

    • Twitter
    • Facebook
    • Instagram
    • LinkedIn
    • YouTube